Stay updated on Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record history reflects a newer submitted version (including a “Study Status” update) and updates the displayed revision label to v3.5.3, replacing an older revision label entry. No concrete change to core study details is visible from the provided change text alone.
    Difference
    0.3%
    Check dated 2026-04-25T05:28:57.000Z thumbnail image
  2. Check
    17 days ago
    No Change Detected
  3. Check
    39 days ago
    Change Detected
    Summary
    The history now shows a new revision entry v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T03:10:39.000Z thumbnail image
  4. Check
    53 days ago
    Change Detected
    Summary
    The record history now includes Revision: v3.4.3 and removes Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T18:40:11.000Z thumbnail image
  5. Check
    75 days ago
    Change Detected
    Summary
    The page history shows Revision: v3.4.2 in place of v3.4.1 in the footer, indicating a minor site update. This change does not affect study data or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T03:54:47.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The history now includes a new site revision label v3.4.1 and removes v3.4.0. This is a minor platform update and does not affect study data or record content.
    Difference
    0.1%
    Check dated 2026-02-05T01:38:11.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle, color-coded highlights (green for additions, red for deletions), and an updated Revision: v3.4.0 label along with wording changes to No FEAR Act data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-01-28T22:52:03.000Z thumbnail image

Stay in the know with updates to Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.